Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck to appeal EU rejection of COVID-19 drug

February 27, 2023
Medical Communications

Life science giant Merck & Co has announced that it will appeal the EU’s Committee for Medicinal Products for Human …

News

Incyte Announces Positive CHMP Opinion for Ruxolitinib Cream (Opzelura™) for the Treatment of Non-segmental Vitiligo in Adults and Adolescents

February 24, 2023
Business Services

WILMINGTON, Del. – February 24, 2023 – Incyte (Nasdaq:INCY) today announced that the European Medicines Agency (EMA) Committee for Medicinal …

News
Press release

Janssen Receives Positive CHMP Opinion for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) Plus Prednisone or Prednisolone for the Treatment of Adult Patients with BRCA1/2 Gene-Mutated Metastatic Castration Resistant Prostate Cancer

February 24, 2023
Business Services

BEERSE, Belgium, 24 February 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for …

News
Press release

Automata launches the LINQ platform to fully automate workflows and the transport of labware in every lab space

February 24, 2023
Business Services

24th February 2023 – Automata, a leading automation company powering life science labs to fully automate their workflows, today launches

News
Press release

AviadoBio Signs Exclusive License Agreement with Neurgain Technologies for Novel Gene Therapy Spinal Delivery Technology

February 24, 2023
Business Services

LONDON–(BUSINESS WIRE)–AviadoBio, a pioneering gene therapy company developing and delivering transformative medicines for neurodegenerative disorders and Neurgain Technologies, Inc., an …

News
Press release

Sanofi and Glooko partner on ‘connected insulin’ tech

February 24, 2023
Medical Communications

Big pharma company Sanofi aims to develop insulin-based therapies that can be connected with glucose monitoring devices, making it easier …

News

Mologic Inc’s COVID-19 rapid antigen self-test receives FDA Emergency Use Authorization for home use

February 24, 2023
Medical Communications

US subsidiary of Global Access Diagnostics (GADx) ‒ a developer of lateral flow and rapid diagnostic technologies, products and services …

News

NICE approved BMS’s Opdivo for lung cancer

February 24, 2023
Medical Communications

Bristol-Myers Squibb’s (BMS) immunotherapy drug Opdivo (nivolumab) has become the first to be cleared for NHS use alongside chemotherapy as …

News

Moda Living and LloydsPharmacy partner to offer residents prescription service

February 24, 2023
Medical Communications

Moda Living has announced a partnership with LloydsPharmacy to bring residents a ‘Health Concierge Service’ through VideoGP.   VideoGP will …

News

UiPath Helps Mitsubishi Tanabe Pharma Accelerate Business Operational Efficiency

February 23, 2023
Business Services

February 23, 2023 – UiPath (NYSE: PATH), a leading enterprise automation software company, today announced that Mitsubishi Tanabe Pharma Corporation, …

News
Press release

NICE recommends first immunotherapychemotherapy combination for neoadjuvant treatment of resectable non-small-cell lung cancer

February 23, 2023
Business Services

(Uxbridge, Middlesex, 22 February 2023) – Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care …

News
Press release

LEADING BUILD TO RENT OPERATOR LAUNCHES SECTOR-FIRST PRESCRIPTION SERVICE WITH NATIONAL PHARMACY CHAIN

February 23, 2023
Business Services

Moda Living, the UK’s leading developer and operator of rental communities, has today announced a partnership with VideoGP by LloydsPharmacy, …

News
Press release

Pandemic Antiviral Discovery (PAD) makes first investments to support the development of new antiviral medicines for future pandemics

February 23, 2023
Business Services

Today, the partners in Pandemic Antiviral Discovery (PAD) initiative announced grants totalling more than USD 26 million for 14 research …

News
Press release

8 out of 10 pharmaceutical companies say developing Covid tests and vaccines has impacted their development pipeline

February 23, 2023
Business Services

LONDON 23rd February 2023 

News
Press release

BiomX shares positive data from first bacteriophage trial

February 23, 2023
Research and Development

BiomX has shared data from a new study in cystic fibrosis (CF) patients, assessing whether bacteriophages could be a new …

News

Redx Pharma agrees to $425m all-share merger with Jounce Therapeutics

February 23, 2023
Research and Development

UK-based clinical-stage biotech company Redx Pharma has agreed to a $425m all-share merger with US drug research business Jounce Therapeutics. …

News

AstraZeneca signs $63m agreement for gastric cancer treatment

February 23, 2023
Medical Communications

AstraZeneca has announced that it has signed an exclusive license agreement (ELA) with KYM Biosciences Inc for CMG901, which is …

News

£1.6bn of research and development funding “surrendered” back to UK Treasury

February 23, 2023
Medical Communications

A pot of £1.6bn which was originally allocated as the UK’s contribution to the €96bn Horizon Europe research funding programme …

News

OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology

February 22, 2023
Business Services

Nantes, France – February 22, 2023, 6:00 p.m.

News
Press release

Karyopharm and Menarini gain full MHRA approval for multiple myeloma drug

February 22, 2023
Research and Development

Pharmaceutical companies Karyopharm Therapeutics and Menarini Group have announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) have …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026